What are the appropriate dosing regimens, renal adjustments, contraindications, and alternatives for Bactrim DS (trimethoprim‑sulfamethoxazole)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bactrim DS (Trimethoprim-Sulfamethoxazole) Dosing and Clinical Use

For most adult indications, Bactrim DS (trimethoprim 160 mg/sulfamethoxazole 800 mg) is dosed as one double-strength tablet twice daily, with duration and renal adjustments varying by indication.

Standard Adult Dosing by Indication

Uncomplicated Cystitis (UTI)

  • Dose: 1 DS tablet twice daily for 3 days 1
  • Critical caveat: Only use if local E. coli resistance rates are <20% or if the organism is known to be susceptible 1
  • Alternative consideration: If resistance exceeds 20% or if used for UTI in the previous 3 months, choose nitrofurantoin or fluoroquinolones instead 1

Complicated UTI/Pyelonephritis

  • Dose: 1 DS tablet twice daily for 10-14 days 2
  • Evidence for shorter durations (7 days) exists but requires further validation 3

Acute Exacerbations of Chronic Bronchitis

  • Dose: 1 DS tablet twice daily for 14 days 2

Shigellosis

  • Dose: 1 DS tablet twice daily for 5 days 2

Pertussis (Alternative Agent)

  • Dose: Trimethoprim 320 mg/sulfamethoxazole 1,600 mg daily (equivalent to 2 DS tablets) in 2 divided doses for 14 days 4
  • Contraindicated: In infants <2 months, pregnant women, and nursing mothers due to kernicterus risk 4

Q Fever in Pregnancy

  • Dose: 1 DS tablet (160 mg/800 mg) twice daily throughout pregnancy 5
  • This is the only safe option for pregnant women with acute Q fever 5

Pneumocystis jirovecii Pneumonia (PCP)

Treatment:

  • High-dose regimen: 75-100 mg/kg/day sulfamethoxazole + 15-20 mg/kg/day trimethoprim divided every 6 hours for 14-21 days 2
  • For an 80 kg adult: approximately 2-2.5 DS tablets every 6 hours
  • Emerging evidence: Lower doses (TMP 10 mg/kg/day) may provide adequate efficacy with fewer adverse events 6, 7, 8

Prophylaxis:

  • Standard: 1 DS tablet daily 2
  • Alternative for hemodialysis patients: <6 single-strength tablets/week (low-dose) shows equivalent efficacy with significantly lower discontinuation rates (12.1% vs 35.6%, P=0.019) 9

MRSA Infections (Alternative Agent)

Osteomyelitis:

  • Dose: TMP 3.5-4.0 mg/kg every 8-12 hours (approximately 2 DS tablets twice daily for an 80 kg adult) plus rifampin 600 mg daily 10

CNS Infections (meningitis, brain abscess):

  • Dose: TMP 5 mg/kg every 8-12 hours 10

Renal Dose Adjustments

This is critical and frequently overlooked:

Creatinine Clearance Dosing Adjustment
>30 mL/min Standard dosing [2]
15-30 mL/min 50% of usual dose [2]
<15 mL/min Use not recommended [2]

For hemodialysis patients:

  • Administer after dialysis to prevent premature drug removal 11
  • Consider low-dose prophylaxis regimens (<6 SS tablets/week) for PCP prevention 9
  • For CRRT: TMP 10 mg/kg/day divided every 12 hours may be appropriate initial dosing 12

Key principle: Dosing frequency should be reduced in renal insufficiency, but the milligram dose per administration should be maintained to preserve concentration-dependent bactericidal effects 11, 13

Pediatric Dosing

General principle: 40 mg/kg/day sulfamethoxazole + 8 mg/kg/day trimethoprim divided every 12 hours 2

Absolute contraindication: Infants <2 months of age due to kernicterus risk 4, 2

PCP prophylaxis in children: 750 mg/m²/day sulfamethoxazole + 150 mg/m²/day trimethoprim divided twice daily, 3 consecutive days per week (maximum: 1600 mg SMX/320 mg TMP daily) 14, 2

Contraindications

Absolute:

  • Hypersensitivity to trimethoprim or sulfonamides 4
  • Infants <2 months of age 4, 2
  • Pregnancy (except for Q fever where it's the only option) 4
  • Nursing mothers 4
  • Megaloblastic anemia due to folate deficiency 4

Relative (use with extreme caution):

  • Severe renal impairment (CrCl <15 mL/min) 2
  • Severe hepatic impairment 4
  • Blood dyscrasias 4
  • G6PD deficiency (risk of hemolysis)

Critical Drug Interactions

Requires dose adjustment or monitoring:

  • Methotrexate: Increased toxicity risk 4
  • Warfarin/oral anticoagulants: Enhanced anticoagulation 4
  • Antidiabetic agents: Risk of hypoglycemia 4
  • Phenytoin: Increased phenytoin levels 4
  • Thiazide diuretics: Increased risk of thrombocytopenia 4

Adverse Effects and Monitoring

Common adverse effects:

  • Gastrointestinal disturbances (nausea, vomiting, anorexia)
  • Hypersensitivity skin reactions
  • Hyperkalemia (trimethoprim blocks potassium excretion)

Serious but rare:

  • Stevens-Johnson syndrome/toxic epidermal necrolysis 4
  • Blood dyscrasias (thrombocytopenia, neutropenia) 4
  • Hepatic necrosis 4
  • Crystalluria (maintain adequate hydration) 4

Monitoring recommendations:

  • Baseline: CBC with differential, platelet count, renal function 14
  • During therapy: Monthly CBC for prolonged therapy 14
  • Maintain adequate fluid intake to prevent crystalluria and renal stones 4

Alternatives When Bactrim Cannot Be Used

For uncomplicated cystitis:

  • Nitrofurantoin 100 mg twice daily for 5 days (first-line alternative) 1
  • Fluoroquinolones for 3 days (reserve for resistant cases) 1
  • Fosfomycin 3 g single dose (lower efficacy) 1

For PCP:

  • Dapsone 100 mg daily (not available in all formulations) 14
  • Aerosolized pentamidine 300 mg every 4 weeks for prophylaxis in children ≥5 years 14

For pertussis:

  • Azithromycin or clarithromycin (macrolides are first-line) 4

Pregnancy Classification

FDA Pregnancy Category C 4

  • Animal studies show adverse fetal effects
  • No adequate human studies exist
  • Exception: For Q fever in pregnancy, Bactrim DS throughout pregnancy is the recommended treatment despite Category C classification 5

References

Research

Clinical use of trimethoprim/sulfamethoxazole during renal dysfunction.

DICP : the annals of pharmacotherapy, 1989

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.